Individuality: the barrier to optimal immunosuppression.
about
A Novel Derivative of (-)mycousnine Produced by the Endophytic Fungus Mycosphaerella nawae, Exhibits High and Selective Immunosuppressive Activity on T Cells.Chemical genetics to identify NFAT inhibitors: potential of targeting calcium mobilization in immunosuppressionMesenchymal stem cells as a therapeutic tool to treat sepsis.Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapy.Evaluation of alloreactivity in kidney transplant recipients treated with antithymocyte globulin versus IL-2 receptor blocker.Hematopoietic chimerism and transplantation tolerance: a role for regulatory T cells.Tacrolimus enhances the potency of posaconazole against Rhizopus oryzae in vitro and in an experimental model of mucormycosisThe calcineurin pathway inhibitor tacrolimus enhances the in vitro activity of azoles against Mucorales via apoptosisImmunosuppressive peptides and their therapeutic applications.Molecular mechanisms of cell death: central implication of ATP synthase in mitochondrial permeability transition.Phytotoxic, Antifungal and Immunosuppressive Metabolites from Aspergillus terreus QT122 Isolated from the Gut of Dragonfly.LY294002 and rapamycin co-operate to inhibit T-cell proliferation.Heat shock protein 90 and calcineurin pathway inhibitors enhance the efficacy of triazoles against Scedosporium prolificans via induction of apoptosis.[Study on the Effect of Immunosuppressive Agent FK506 on Growth and Migration of Lung Cancer Cell].Extracellular Matrix Bioscaffolds as Immunomodulatory Biomaterials.A new potent immunosuppressive isoflavanonol from Campylotropis hirtella.Adipose-derived stem cells versus bone marrow-derived stem cells for vocal fold regeneration.Cyclophosphamide for Refractory Acute Cellular Rejection After Lung Transplantation.
P2860
Q33871002-6DAA98E7-990A-413F-85D7-B5F87FB418F3Q34831211-4020540A-FDD4-4E9A-9B3F-541C15CE5C07Q35205670-19309632-7675-48B6-A9BF-D804C66275CCQ35418255-A0014414-777F-4752-8BA2-8AA5D3E0193BQ35580676-6C2C4960-6573-4A42-BBB7-8D1706B2D5E7Q35928393-C0D5B7D0-5B0A-40B9-B78A-D52A8A4590E4Q36584655-1F2C9CFE-5511-4C92-9BA4-12CDE93551AEQ37264097-47507B22-FB3F-420B-A5B9-743C6406C0DCQ38170857-2D50CB06-D93B-4448-BA31-C62B4D7CCEA2Q38204222-52F82BB8-91AD-4BDE-9CCB-FA82916DFA72Q39187681-3D01F9BC-E9E0-4841-B069-F866D79ECCDEQ40444950-6D3F47EA-EDCE-40B0-A032-3F94B94C20CCQ42212950-85E23FE4-2E05-4648-B96E-11A63E8AD042Q50521191-63BDC6BB-4B4F-4BC0-B367-DC249939E168Q50895830-356B1776-4D02-44DC-B823-079FAB7747DAQ53402977-9EB00E50-8D6D-4FC0-ABD8-255AB5B3117CQ54198230-D9EF54C7-2DA9-4362-85D0-6C2A7F2868B5Q55268453-8AB9AC77-EC38-48C7-A341-15A4BFA5C85E
P2860
Individuality: the barrier to optimal immunosuppression.
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Individuality: the barrier to optimal immunosuppression.
@ast
Individuality: the barrier to optimal immunosuppression.
@en
type
label
Individuality: the barrier to optimal immunosuppression.
@ast
Individuality: the barrier to optimal immunosuppression.
@en
prefLabel
Individuality: the barrier to optimal immunosuppression.
@ast
Individuality: the barrier to optimal immunosuppression.
@en
P356
P1476
Individuality: the barrier to optimal immunosuppression.
@en
P2093
Barry D Kahan
P304
P356
10.1038/NRI1204
P577
2003-10-01T00:00:00Z